Diode Laser 940 Nm Versus Electrosurgical Device During Second Stage Implant Surgery on Bone and Soft Tissue Healing
Launched by HAMS HAMED ABDELRAHMAN · Jan 29, 2024
Trial Information
Current as of March 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adequate zone of keratinized mucosa.
- • Osseointegrated Implants ready for second-stage surgery.
- Exclusion Criteria:
- • Heavy smokers due to increased risk of infection, delayed wound healing, and poor immune response.
- • Medically compromised patients due to affection of the peri-implant health and tissue maintenance.
- • Bad oral hygiene
- • Patients with an exposed cover screw
- • Evidence of bone loss in the preoperative peri-apical radiograph.
About Hams Hamed Abdelrahman
Hams Hamed Abdelrahman is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a focus on ethical practices and regulatory compliance, the organization prioritizes patient safety and data integrity in all its clinical trials. Leveraging a diverse team of experienced professionals, Hams Hamed Abdelrahman collaborates with healthcare providers and research institutions to facilitate the development of new therapies and interventions that address unmet medical needs across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
